GIAZO Trademark

Trademark Overview

On Monday, June 27, 2011, a trademark application was filed for GIAZO with the United States Patent and Trademark Office. The USPTO has given the GIAZO trademark a serial number of 85356973. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 25, 2019. This trademark is owned by Salix Pharmaceuticals, Inc.. The GIAZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of and treatment of gastrointestinal diseases and disorders with prescription pharmaceutical preparations containing balsalazide or balsalazide disodium
giazo

General Information

Serial Number85356973
Word MarkGIAZO
Filing DateMonday, June 27, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 25, 2019
Registration Number4305933
Registration DateTuesday, March 19, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of and treatment of gastrointestinal diseases and disorders with prescription pharmaceutical preparations containing balsalazide or balsalazide disodium

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 25, 2019
Primary Code005
First Use Anywhere DateThursday, December 20, 2012
First Use In Commerce DateThursday, December 20, 2012

Trademark Owner History

Party NameSalix Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27615
Party NameSalix Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27615
Party NameSalix Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events

Event DateEvent Description
Wednesday, November 25, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, October 25, 2019CANCELLED SEC. 8 (6-YR)
Monday, March 19, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 19, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 19, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 8, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 19, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, February 9, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 8, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, February 7, 2013ASSIGNED TO LIE
Saturday, January 26, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 22, 2013STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 17, 2013USE AMENDMENT FILED
Thursday, January 17, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, July 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2012EXTENSION 1 GRANTED
Tuesday, July 10, 2012EXTENSION 1 FILED
Friday, July 27, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 10, 2012TEAS EXTENSION RECEIVED
Tuesday, January 17, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 14, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2011ASSIGNED TO EXAMINER
Friday, July 1, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 30, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

giazo balsalazide pharmaceutical preparations containing disodium prescription diseases prevention treatment gastrointestinal